Get Quartz in your inbox

Free daily briefing on global business news.

Eli Lilly raised its outlook for a third time this year thanks to soaring Zepbound sales

Lilly's revenue guidance rises to $91 billion to $92 billion from $85 billion to $87 billion as quarterly sales climb 39%

jetcityimage / Getty Images

Eli Lilly $LLY raised its 2026 revenue forecast to $91 billion to $92 billion on Thursday after third-quarter revenue climbed 39% to $24.4 billion, led by Mounjaro and Zepbound.

The company's previous range was $85 billion to $87 billion. It is the third guidance increase this year for Lilly, according to MarketWatch. Eli Lilly stock rose more than 4% in premarket trading.

Non-GAAP........

© Quartz